Sean Lee
Stock Analyst at HC Wainwright & Co.
(0.74)
# 2,907
Out of 4,412 analysts
60
Total ratings
21.31%
Success rate
-23.81%
Average return
Main Sectors:
Top Industries:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VSTM Verastem | Reiterates: Buy | $18 | $9.98 | +75.35% | 7 | Mar 19, 2024 | |
| CTSO Cytosorbents | Reiterates: Neutral | $1 | $0.81 | +23.46% | 8 | Mar 15, 2024 | |
| GRTS Gritstone bio | Reiterates: Buy | $7 | $0.80 | +775.00% | 8 | Mar 6, 2024 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $20 | $12.62 | +58.48% | 7 | Mar 4, 2024 | |
| MYO Myomo | Initiates: Buy | $6.5 | $3.27 | +98.78% | 1 | Dec 15, 2023 | |
| CASI CASI Pharmaceuticals | Maintains: Buy | $10 → $12 | $2.35 | +411.73% | 6 | Nov 15, 2023 | |
| THMO ThermoGenesis Holdings | Reiterates: Buy | $5 | $0.69 | +628.76% | 6 | Nov 14, 2023 | |
| PSTV Plus Therapeutics | Reiterates: Buy | $8 | $1.74 | +359.77% | 7 | Aug 15, 2023 | |
| MNPR Monopar Therapeutics | Reiterates: Buy | $17 | $0.66 | +2,475.37% | 5 | Jun 1, 2023 | |
| KZIA Kazia Therapeutics | Upgrades: Buy | $2 | $0.33 | +497.37% | 2 | Apr 11, 2023 | |
| AKTX Akari Therapeutics, | Initiates: Buy | $30 | $1.48 | +1,927.03% | 1 | Dec 5, 2022 | |
| VIRI Virios Therapeutics | Downgrades: Neutral | n/a | $0.45 | - | 2 | Sep 20, 2022 |
Verastem
Mar 19, 2024
Reiterates: Buy
Price Target: $18
Current: $9.98
Upside: +75.35%
Cytosorbents
Mar 15, 2024
Reiterates: Neutral
Price Target: $1
Current: $0.81
Upside: +23.46%
Gritstone bio
Mar 6, 2024
Reiterates: Buy
Price Target: $7
Current: $0.80
Upside: +775.00%
Alphatec Holdings
Mar 4, 2024
Reiterates: Buy
Price Target: $20
Current: $12.62
Upside: +58.48%
Myomo
Dec 15, 2023
Initiates: Buy
Price Target: $6.5
Current: $3.27
Upside: +98.78%
CASI Pharmaceuticals
Nov 15, 2023
Maintains: Buy
Price Target: $10 → $12
Current: $2.35
Upside: +411.73%
ThermoGenesis Holdings
Nov 14, 2023
Reiterates: Buy
Price Target: $5
Current: $0.69
Upside: +628.76%
Plus Therapeutics
Aug 15, 2023
Reiterates: Buy
Price Target: $8
Current: $1.74
Upside: +359.77%
Monopar Therapeutics
Jun 1, 2023
Reiterates: Buy
Price Target: $17
Current: $0.66
Upside: +2,475.37%
Kazia Therapeutics
Apr 11, 2023
Upgrades: Buy
Price Target: $2
Current: $0.33
Upside: +497.37%
Akari Therapeutics,
Dec 5, 2022
Initiates: Buy
Price Target: $30
Current: $1.48
Upside: +1,927.03%
Virios Therapeutics
Sep 20, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.45
Upside: -